title: [Drug clinics. How I treat HIV infections. II. Nucleoside reverse transcriptase inhibitors].
authors.affiliation: Recherches FNRS, Université de Liège.
authors.forename: M
authors.initials: M
authors.lastname: Moutschen
authors.forename: D
authors.initials: D
authors.lastname: Nkoghe
authors.forename: P
authors.initials: P
authors.lastname: Léonard
authors.forename: J
authors.initials: J
authors.lastname: Demonty
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006678:HIV / Q000187:drug effects; D015658:HIV Infections / Q000188:drug therapy*; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors*; D006801:Humans; D009705:Nucleosides / Q000627:therapeutic use*; D010766:Phosphorylation / Q000187:drug effects; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D009705:Nucleosides; D018894:Reverse Transcriptase Inhibitors; D054303:HIV Reverse Transcriptase
vernacular_title: Pharma-clinics. Comment je traite ... Une infection par le VIH. II. Inhibiteurs nucléosidiques de la transcriptase reverse.